Valued at $258.0M at its later-stage round, Nov 2025. Nothing has traded since.
- ·The complete investor list: 12 names
- ·Everyone on the team, board and advisors included
- ·Watch TRIANA Biomedicines: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
TRIANA Biomedicines funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Later Stage VC (Series B) | $120.1M | ▮ | ▮ |
| Apr 2022 | Early Stage VC (Series A) | $110.0M | ▮ | ▮ |
Membership and data by Private Market View
TRIANA Biomedicines valuation
TRIANA Biomedicines was valued at $258 million at its later-stage round in Nov 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has TRIANA Biomedicines raised?
TRIANA Biomedicines has raised $246 million across 2 recorded rounds since 2022. The largest was a $120 million Series B in Nov 2025.
TRIANA Biomedicines has filed 3 Form Ds with the SEC since 2022, most recently in Dec 2025 ($120 million sold to 20 investors).
Comparable companies
Comparable discovery tools (healthcare) names by valuation on PrivateMarketView: Scipher Medicine ($496 million), Outpace Bio ($220 million) and Nature's Toolbox ($71 million).
How TRIANA Biomedicines's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For TRIANA Biomedicines, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about TRIANA Biomedicines
- What is TRIANA Biomedicines worth?
- TRIANA Biomedicines is valued at $258.0M as of Oct 2026. Valued at $258.0M at its later-stage round, Nov 2025. Nothing has traded since.
- How much has TRIANA Biomedicines raised?
- TRIANA Biomedicines has raised $246.1M in total funding across 2 recorded rounds.
- When did TRIANA Biomedicines last raise?
- TRIANA Biomedicines last raised in Nov 2025 (Later Stage VC (Series B)), raising $120.1M.